Streamline Health Solutions Inc. Executive Compensation (FY23)
STRM · Executive and director compensation, fiscal 2023 only
Chief executive, fiscal 2023 ◇ Benjamin Stilwill | Latest say-on-pay support = June 15, 2023 |
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
The Streamline Health Solutions Inc. brief, $500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Data as of October 22, 2026Latest filing (DEF 14A): May 13, 2024
7 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Intel, one year, every company
83 figures on this page: 77 cited to the filing that reported them, 6 calculated from figures it prints. See the citations
Frequently asked questions
Answers drawn from the data on this page.
Who is Streamline Health Solutions Inc.'s chief executive and what were they paid?
Benjamin Stilwill was paid $593,901 in total compensation as Chief Executive Officer for fiscal 2023.
What was Streamline Health Solutions Inc.'s say-on-pay result?
For fiscal 2023, shareholders backed the say-on-pay proposal with 99.8% of votes cast for or against in favor at the meeting held June 15, 2023.
Which companies are in Streamline Health Solutions Inc.'s peer group?
The disclosed peer group includes American Software, Inc., Model N, Inc., National Research Corporation, Optimize-Rx Corporation and PaySign, Inc., among others.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Thomas Gibson Former Senior Vice President and Chief Financial Officer (5) | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Wyche Green Executive Chairman | ◇ | — | ◇ | — | — | — | — | ◇ |
Benjamin Stilwill Chief Executive Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Wendy Lovvorn Chief People Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Bryant Reeves Chief Financial Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2024
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Benjamin Stilwill | RSA | — | — | — | ◇ | — | — | — |
| Benjamin Stilwill | RSA | — | — | — | ◇ | — | — | — |
| Bryant Reeves | RSA | — | — | — | ◇ | — | — | — |
| Bryant Reeves | RSA | — | — | — | ◇ | — | — | — |
| Thomas Gibson | RSA | — | — | — | ◇ | — | — | — |
| Wendy Lovvorn | RSA | — | — | — | ◇ | — | — | — |
| Wendy Lovvorn | RSA | — | — | — | ◇ | — | — | — |
| Wyche Green | RSA | — | — | — | ◇ | — | — | — |
| Wyche Green | RSA | — | — | — | ◇ | — | — | — |
| Wyche Green | RSA | — | — | — | ◇ | — | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2024 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Wyche Green | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Wendy Lovvorn | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Benjamin Stilwill | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| Bryant Reeves | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director compensation
What each non-employee director was paid.
Fiscal 2024
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Judith E. Starkey | — | — | — | — | — | — | — |
Justin J. Ferayorni | — | — | — | — | — | — | — |
Kenan H. Lucas | — | — | — | — | — | — | — |
Jonathan R. Phillips | — | — | — | — | — | — | — |
Matthew W. Etheridge, Wyche T. “Tee” Green III and Benjamin L. Stilwill served on the board in fiscal 2024 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
Equity is delivered as Restricted Stock.
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2024
- American Software, Inc. AMSWA
- Model N, Inc. MODN
- National Research Corporation NRC
- Optimize-Rx Corporation symbol not shown
- PaySign, Inc. PAYS
- Phreesia, Inc. PHR
- RCM Technologies, Inc. RCMT
- Verb Technology Company, Inc. symbol not shown
- Vocera Communications, Inc. RBBN
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2023 | June 15, 2023 | = | ◇ | ◇ | ◇ |
| 2022 | June 7, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | May 21, 2020 | = | ◇ | ◇ | ◇ |
| 2019 | May 22, 2019 | = | ◇ | ◇ | ◇ |
| 2017 | June 1, 2017 | = | ◇ | ◇ | ◇ |
| 2016 | May 25, 2016 | = | ◇ | ◇ | ◇ |
Ask our research desk — $99, 24h, every figure cited to its filing.
Sample answer — “What is the CEO’s total compensation?”
- Benjamin Stilwill (Chief Executive Officer), FY2023 total compensation $593,901 (base salary $289,693) [exec_comp, SEC accession 0001437749-24-016287, filed 2024-05-13]What this page does not include
Everything above is a fact Streamline Health Solutions Inc. disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Streamline Health Solutions Inc. sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
83 figures on this page: 77 cited to the filing that reported them, 6 calculated from figures it prints.
77 cited to the filing
6 calculated from the filing
Documents cited
- 0001437749-24-016287
- 0001493152-23-021849
- 0001493152-22-016177
- 0001493152-20-010472
- 0001104659-19-031466
- 0001104659-17-036977
- 0001104659-16-124479
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Streamline Health Solutions Inc. executive compensation, FY2023.” https://intel.velarion.ai/comp/STRM (accessed 2026).
Short form: data: Velarion
The Streamline Health Solutions Inc. brief, $500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
7 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Streamline Health Solutions Inc. and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Peers Streamline Health Solutions Inc. discloses
The companies named in STRM's own disclosed peer group.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}